ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Proxima Clinical Research Honored by Hermes Creative Awards

Proxima CRO recognized with two platinum awards, two gold awards, and five honorable mentions for its creative branding, marketing, and videos

HOUSTON, TX / ACCESSWIRE / April 27, 2022 / Proxima Clinical Research ("Proxima CRO"), a contract research organization ("CRO") guiding emerging medical device and pharmaceutical companies from the earliest stages of product development through commercialization, announced today its creative work has been honored with two platinum, two gold, and five honorable mentions by Hermes Creative Awards, an international competition recognizing the work of creative professionals.

ProximaCRO, Wednesday, April 27, 2022, Press release picture

The big winner in this recognition is the entire marketing, branding, and communications team at Proxima CRO, which received the Platinum award for their Team Achievement and the ProximaCRO.com Homepage, in tandem with its agencies of choice, Aleberry Creative and Engagement PR & Marketing. The internal 5-person marketing team was hired in Q2 2021, and quickly breathed life into the Proxima CRO superhero brand. Within months, their work has been recognized consistently by international awards companies, like Hermes, AVA Awards, and MarComm Awards.

In addition to the two Platinum awards, Hermes honored the team's work with Gold Awards for its Breakthrough Device Designation Timeline video and Proxima CRO Sales Flyer, and with Honorable Mentions for its LinkedIn Page, Informational Talking Head Campaign, Classifying Your Medical Device video, the CEO eNewsletter, and Employee Spotlight video featuring Regulatory BizDev Strategist Chelsea Isaac.

ProximaCRO, Wednesday, April 27, 2022, Press release picture
ProximaCRO, Wednesday, April 27, 2022, Press release picture

"I am beyond proud of the entire team and brand that we have created together here at Proxima Clinical Research," says Kevin Coker, CEO. "Within weeks, the marketing team brought the vision of our brand to life which has elevated our presence as a best-in-class CRO for emerging life sciences companies."

Receiving accolades by Hermes Creative Awards is a tremendous achievement. Proxima CRO is pleased to join companies such as Dell Technologies, Deloitte Digital, Lockheed Martin, Paramount Pictures, PepsiCo, and USA TODAY, to name a few of the other honorees receiving Platinum and Gold awards from Hermes. A full list of Platinum and Gold Winners can be found at www.hermesawards.com.

About Hermes Creative Awards

Hermes Creative Awards is administered by the Association of Marketing and Communication Professionals (AMCP). Judges are industry professionals who look for companies and individuals whose talent exceeds a high standard of excellence and whose work serves as a benchmark for the industry. There were roughly 6,500 entries from the United States and dozens of other countries in the Hermes Creative Awards 2022 competition. About 17 percent won Platinum-the top award, and around 20 percent won the Gold Award.

About Proxima Clinical Research

Proxima CRO provides regulatory and clinical research expertise to life sciences companies of all sizes and stages, including inventors, emerging companies, and Fortune 500. With headquarters in the Texas Medical Center ("TMC"), the largest medical center in the world, Proxima CRO brings its expertise to hundreds of medical device, pharmaceutical, biotechnology, and diagnostic companies in 17 countries across five continents to further advance the $130 billion industry. Launched in November 2017, Proxima CRO is a registered Delaware C Corporation. For more on Proxima CRO and its growing team, visit ProximaCRO.com.

CONTACT:
Jennifer Horspool
(949)-933-4300
Jennifer.Horspool@proximacro.com

SOURCE: ProximaCRO



View source version on accesswire.com:
https://www.accesswire.com/699017/Proxima-Clinical-Research-Honored-by-Hermes-Creative-Awards

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.